Xtant Medical Partners with Dilon Technologies for Exclusive Distribution of HEMOBLAST® Bellows in the U.S. Xtant Medical and Dilon Technologies announced an exclusive U.S. distribution agreement for the innovative HEMOBLAST® Bellows, enhancing surgical hemostatic solutions.

Xtant Medical Partners with Dilon Technologies for Exclusive Distribution of HEMOBLAST® Bellows in the U.S. #USA #Newport_News #Xtant_Medical #Dilon_Technologies #HEMOBLAST

Xtant Medical and Montana Governor's Office Join Forces for 'Threshold of Life' Memorial Initiative Xtant Medical, in partnership with the Montana Governor's Office, reveals plans for a memorial honoring organ donors. The initiative promotes donation awareness.

Xtant Medical and Montana Governor's Office Join Forces for 'Threshold of Life' Memorial Initiative #United_States #organ_donation #Helena #Xtant_Medical #Montana_Governor

Xtant Medical Achieves Notable Financial Growth in 2025, Reports Positive Earnings Xtant Medical Holdings has released impressive financial results for both the fourth quarter and full year of 2025, showcasing substantial growth in revenue and net income

Xtant Medical Achieves Notable Financial Growth in 2025, Reports Positive Earnings #United_States #financial_results #Belgrade #Surgical_Solutions #Xtant_Medical

Xtant Medical Completes $21.4 Million Deals with Companion Spine for Orthopedic Assets Xtant Medical finalizes $21.4 million transactions with Companion Spine, enhancing focus on biologics while reducing debt. Read more here!

Xtant Medical Completes $21.4 Million Deals with Companion Spine for Orthopedic Assets #United_States #Belgrade #Xtant_Medical #Companion_Spine #Coflex_Assets

Xtant Medical Engages in Significant Musculoskeletal Conference in New Orleans Xtant Medical is poised to feature its innovative surgical solutions at the Canaccord Genuity 2026 Musculoskeletal Conference in early March.

Xtant Medical Engages in Significant Musculoskeletal Conference in New Orleans #United_States #New_Orleans #Xtant_Medical #Sean_Browne #Musculoskeletal_Conference

Xtant Medical Launches Next-Generation nanOss Strata Synthetic Bone Graft for Enhanced Healing Discover Xtant Medical's innovative nanOss Strata synthetic bone graft, designed to improve healing by mimicking human bone structure and increasing biological activity.

Xtant Medical Launches Next-Generation nanOss Strata Synthetic Bone Graft for Enhanced Healing #United_States #Belgrade #Xtant_Medical #nanOss_Strata #Synthetic_Bone_Graft

Xtant Medical Finalizes Sale of Coflex® and Paradigm OUS Businesses to Companion Spine Xtant Medical Holdings, Inc. has completed the sale of certain non-core assets to Companion Spine, marking a strategic pivot towards its core biologics business.

Xtant Medical Finalizes Sale of Coflex® and Paradigm OUS Businesses to Companion Spine #United_States #Belgrade #Xtant_Medical #Companion_Spine #Coflex

Xtant Medical Reports Impressive Q3 2025 Results with Significant Revenue Growth Xtant Medical Holdings, Inc. shows strong financial performance in Q3 2025, achieving substantial revenue growth and a positive net income. The company focuses on innovation and strategic sales.

Xtant Medical Reports Impressive Q3 2025 Results with Significant Revenue Growth #United_States #financial_results #Belgrade #Xtant_Medical #CollagenX

Xtant Medical's New CollagenX™ Set to Transform Surgical Wound Closure Practices Xtant Medical has officially launched CollagenX™, a bovine collagen product aimed at enhancing surgical wound closure, promising improved healing for patients.

Xtant Medical's New CollagenX™ Set to Transform Surgical Wound Closure Practices #United_States #Belgrade #Surgical_Solutions #Xtant_Medical #CollagenX™

Xtant Medical Reports Strong Q2 2025 Financial Results with Growth in Revenue and Profitability Xtant Medical Holdings, Inc. announces Q2 2025 financial results showing an 18% rise in revenue and a return to net profitability, signaling strong performance and strategic focus.

Xtant Medical Reports Strong Q2 2025 Financial Results with Growth in Revenue and Profitability #United_States #Belgrade #Xtant_Medical #OsteoFactor_Pro #XTNT

Xtant Medical's Leadership to Participate in the CG 45th Annual Growth Conference Xtant Medical Holdings, Inc. is set to join the CG 45th Annual Growth Conference, showcasing its innovative surgical solutions. Learn more about their mission.

Xtant Medical's Leadership to Participate in the CG 45th Annual Growth Conference #United_States #Boston #Xtant_Medical #Sean_Browne #Scott_Neils

Xtant Medical Completes Sale of Coflex® and CoFix® Spinal Products to Companion Spine Xtant Medical Holdings announces the sale of Coflex® and CoFix® spinal implants, focusing on strengthening its core business and enhancing financial liquidity.

Xtant Medical Completes Sale of Coflex® and CoFix® Spinal Products to Companion Spine #United_States #Belgrade #Xtant_Medical #Companion_Spine #Coflex

Xtant Medical Unveils OsteoFactor Pro™ to Transform Bone Healing Procedures Xtant Medical has launched OsteoFactor Pro™, a groundbreaking solution for enhancing bone healing in surgical procedures. This innovative product promises substantial benefits for orthopedic surgeons and patients alike.

Xtant Medical Unveils OsteoFactor Pro™ to Transform Bone Healing Procedures #United_States #Belgrade #Xtant_Medical #Orthopedic_Innovation #OsteoFactor_Pro

Xtant Medical Reports Strong Q1 2025 Results with Elevated Revenue Guidance Xtant Medical Holdings, Inc. showcases a robust performance in Q1 2025, with revenue growth and increased guidance promising a bright future for the company.

Xtant Medical Reports Strong Q1 2025 Results with Elevated Revenue Guidance #United_States #Belgrade #Q1_2025 #Xtant_Medical #Trivium_Allograft

Xtant Medical Unveils Trivium™ Bone Graft for Enhanced Surgical Efficacy Xtant Medical has introduced Trivium™, a cutting-edge bone graft solution, enhancing surgical outcomes in orthopedic and spinal care.

Xtant Medical Unveils Trivium™ Bone Graft for Enhanced Surgical Efficacy #USA #Belgrade #Bone_Graft #Xtant_Medical #Trivium

Xtant Medical Reports Strong Q1 Growth Amid Shareholding Changes Xtant Medical Holdings, Inc. shares insights into a secondary stock sale by OrbiMed and previews significant revenue growth for Q1 2025, citing an increase of up to 19%.

Xtant Medical Reports Strong Q1 Growth Amid Shareholding Changes #USA #Belgrade #Xtant_Medical #OrbiMed_Advisors #Nantahala_Capital